Table 11. Achillion isothiazoloquinolone SAR for MRSA (MIC) and cytotoxicity in Hep2 cells (CC50). Ciprofloxacin 15, moxifloxacin, and gemifloxacin 102 serve as reference compounds.
Compound | R6 | R7 | X |
MRSAa
MIC (µg/ml) |
Hep2 cellsb
CC50 (µg/ml)c [topo II EC2 (µg/ml)]c,d |
---|---|---|---|---|---|
91 | F | CH | 2 | 3 | |
92 | F | COCH3 | 0.5 | 8 [32] | |
93 | H | COCH3 | 2 | 40 | |
94 | F | CH | 1 | 1 | |
95 | F | COCH3 | 0.5 | 6 [15] | |
96 | H | COCH3 | 2 | 19 | |
97 | F | COCH3 | 2 | 10 | |
98 | F | COCH3 | 0.25 | 4 | |
99 | F | COCH3 | 4 | >43 | |
100 ACH702 |
F | COCH3 | 0.06 | 4 | |
101 | F | COCH3 | 2 | 28 | |
15 ciprofloxacin |
F | CH | 32 | >33 [>50] | |
12 moxifloxacin |
F | COCH3 | 2 | >40 [>60] |